組織診断の技術と世界市場

Report Highlights

The global market for tissue diagnostics is estimated to increase from $8.9 billion in 2024 to reach $12.4 billion by 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 through 2029.

組織診断の世界市場は、2024 年の 89 億ドルから 2029 年までに 124 億ドルに達し、2024 年から 2029 年までの年間平均成長率 (CAGR) は 7.0% になると推定されています。

Report Scope

The report provides an analysis of the tissue diagnostics market, along with a competitive landscape and profiles of leading companies that include their revenues, product portfolios and recent activities. The report analyzes market dynamics, including drivers, limitations, challenges and opportunities, and discusses current and potential market size. The report will enable companies in the industry to make informed decisions about the production and licensing of goods and services. Organizations, distributors and exporters should find useful information about market developments and trends.

The study segments the market on multiple bases. By product type, the market is segmented into instruments and reagents (reagents/test kits/consumables of tissue diagnostics).

By segment type, the market is divided into histopathology, which includes hematoxylin and eosin stains (H&E) and immunohistochemistry (IHC); molecular pathology, which includes in situ hybridization (ISH), polymerase chain reaction (PCR) and next-generation sequencing (NGS); microbiological testing, which includes general culture testing and antimicrobial susceptibility testing and identification (AST/ID); and digital pathology.

Regional market analysis is provided for all the major segments. The regions are North America; Europe; Asia-Pacific; Latin America; and Rest of the World (RoW), which in this report consists of the Middle East and Africa. The report also provides country-level analyses of markets and market segments.

The report covers only tissue sample-based tests. The liquid biopsy market; swab, saliva and urine-based tests; and the service testing market of tissue diagnostics are outside the scope of the report.

In this report, the tissue diagnostics market is segmented by:

Product type:

– Reagents.

– Instruments.

Segments:

– Histopathology (H&E, IHC).

– Molecular pathology (ISH, PCR and NGS).

– Microbiological testing (general culture testing, AST/ID testing) .

– Digital pathology.

Technology:

– H&E.

– IHC.

– ISH.

– PCR.

– NGS.

– Digital pathology.

Applications:

– Oncology.

– Tissue typing.

– Pathogen detection and AST.

End users:

– Professional laboratories.

– Emergency care units.

– Academic and research institutes.

Report Synopsis

Report Includes

– 40 data tables and 42 additional tables

– An analysis of the global market trends for tissue diagnostics, with market revenue data from 2022 to 2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029

– Estimates of the size and revenue prospects of the global market, along with a market share analysis by type of test, technology, application, end user and region

– Facts and figures pertaining to the market dynamics, technical advances, regulations, and the impact of macroeconomic factors

– Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses

– An analysis of patents, emerging trends and developments in the industry

– Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook

– Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies

– Company profiles of major players within the industry, including F. Hoffmann-La Roche Ltd., Danaher Corp., Agilent Technologies Inc., Thermo Fisher Scientific Inc., and Illumina Inc.

Table of Contents

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview
Market Overview and Definitions
Immunohistochemistry (IHC)
In Situ Hybridization
Polymerase Chain Reaction
Next-Generation Sequencing
General Culture Testing

Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Incidence of Cancer Cases
Companion Diagnostics in Cancer Treatment
Importance of Early Cancer Testing
Raising Awareness of Early Signs of Cancer
Aging Population
Market Opportunities
Enhancing Access
Digital Pathology
Partnerships
Market Restraints
Cost of Tissue Diagnostic Tests
Competing Technologies
Turnaround Time
Market Challenges
Lack of Skilled Professionals
Complex Sample Preparation and Handling

Chapter 4 Emerging Technologies and Developments
Overview
Digital Pathology and AI Integration
3D Tissue Pathology and AI
Fluorescent In Situ Sequencing

Chapter 5 Tissue Diagnostics Testing Market
Segmentation Breakdown
Market Breakdown
Market Breakdown, by Product Type
Market Breakdown, by Technology
Market Breakdown, by Segment
Histopathology Market
Molecular Pathology Market
Microbiology Testing Market
Digital Pathology Market
Market Breakdown, by Application
Market Breakdown, by End User
Geographic Breakdown
Market Breakdown, by Region
North America
Europe
Asia-Pacific
Latin America
Rest of the World

Chapter 6 Competitive Intelligence
Industry Scenario
Competitive Landscape

Chapter 7 Sustainability in the Market for Tissue Diagnostics: An ESG Perspective
Introduction to ESG
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC

Chapter 8 Appendix
Research Methodology
References
Acronyms
Company Profiles
ABBOTT
AGILENT TECHNOLOGIES INC.
BD
BIOCARE MEDICAL LLC.
BIOMERIEUX
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
KONINKLIJKE PHILIPS N.V.
MERCK KGAA
MYRIAD GENETICS INC.
QIAGEN
THERMO FISHER SCIENTIFIC INC.
ZYTOVISION GMBH

List of Tables

Summary Table : Global Tissue Diagnostics Market, by Product Type, Through 2029

Table 1 : Global Incidence of All Cancers, by Region, 2022-2045

Table 2 : Cancer Cases, by Country, 2022

Table 3 : Incidence of Cancer, by Cancer Type, 2022

Table 4 : Cancer Treatments Based on Specific Tests

Table 5 : Global Tissue Diagnostics Market, Through 2029

Table 6 : Global Tissue Diagnostics Market, by Product Type, Through 2029

Table 7 : Global Tissue Diagnostics Market, by Technology, Through 2029

Table 8 : Global IHC Tissue Diagnostics Market, by Region, Through 2029

Table 9 : Global H&E and Special Stains Diagnostics Market, by Region, Through 2029

Table 10 : Global ISH Tissue Diagnostics Market, by Region, Through 2029

Table 11 : Global PCR Tissue Diagnostics Market, by Region, Through 2029

Table 12 : Global NGS Tissue Diagnostics Market, by Region, Through 2029

Table 13 : Global Digital Pathology Market, by Region, Through 2029

Table 14 : Global Tissue Diagnostics Market, by Segment Type, Through 2029

Table 15 : Global Histopathology Market, by Product Type, Through 2029

Table 16 : Global Histopathology Market, by Region, Through 2029

Table 17 : Global Molecular Pathology Market, by Product Type, Through 2029

Table 18 : Global Molecular Pathology Market, by Region, Through 2029

Table 19 : Global Microbiology Testing Market, by Product Type, Through 2029

Table 20 : Global Microbiology Testing Market, by Region, Through 2029

Table 21 : Global Digital Pathology Market, Through 2029

Table 22 : Global Digital Pathology Market, by Region, Through 2029

Table 23 : Global Tissue Diagnostics Market, by Application, Through 2029

Table 24 : Global Tissue Diagnostics Market, by End User, Through 2029

Table 25 : Global Tissue Diagnostics Market, by Region, Through 2029

Table 26 : North American Tissue Diagnostics Market, by Country, Through 2029

Table 27 : European Tissue Diagnostics Market, by Country, Through 2029

Table 28 : Asia-Pacific Tissue Diagnostics Market, by Country, Through 2029

Table 29 : Latin American Tissue Diagnostics Market, by Country, Through 2029

Table 30 : RoW Tissue Diagnostics Market, Through 2029

Table 31 : ESG: Environmental Overview

Table 32 : ESG: Social Overview

Table 33 : ESG: Governance Overview

Table 34 : Acronyms Used in this Report

Table 35 : Abbott: Company Snapshot

Table 36 : Abbott: Financial Performance, FY 2022 and 2023

Table 37 : Abbott: Product Portfolio

Table 38 : Agilent Technologies Inc.: Company Snapshot

Table 39 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023

Table 40 : Agilent Technologies Inc.: Product Portfolio

Table 41 : Agilent Technologies Inc.: News/Key Developments, 2024

Table 42 : BD: Company Snapshot

Table 43 : BD: Financial Performance, FY 2022 and 2023

Table 44 : BD: Product Portfolio

Table 45 : Biocare Medical LLC.: Company Snapshot

Table 46 : Biocare Medical LLC.: Product Portfolio

Table 47 : Biomerieux: Company Snapshot

Table 48 : Biomerieux: Financial Performance, FY 2022 and 2023

Table 49 : Biomerieux: Product Portfolio

Table 50 : Bio-Rad Laboratories Inc.: Company Snapshot

Table 51 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023

Table 52 : Bio-Rad Laboratories Inc.: Product Portfolio

Table 53 : Danaher Corp.: Company Snapshot

Table 54 : Danaher Corp.: Financial Performance, FY 2022 and 2023

Table 55 : Danaher Corp.: Product Portfolio

Table 56 : Danaher Corp.: News/Key Developments, 2023

Table 57 : F. Hoffmann-La Roche Ltd.: Company Snapshot

Table 58 : F. Hoffmann-La Roche Ltd.: Financials, FY 2022 and 2023

Table 59 : F. Hoffmann-La Roche Ltd.: Product Portfolio

Table 60 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2024

Table 61 : Illumina Inc.: Company Snapshot

Table 62 : Illumina Inc.: Financial Performance, FY 2022 and 2023

Table 63 : Illumina Inc.: Product Portfolio

Table 64 : Illumina Inc.: News/Key Developments, 2024

Table 65 : Koninklijke Philips N.V.: Company Snapshot

Table 66 : Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023

Table 67 : Koninklijke Philips N.V.: Product Portfolio

Table 68 : Merck KGaA: Company Snapshot

Table 69 : Merck KGaA: Financial Performance, FY 2022 and 2023

Table 70 : Merck KGaA: Product Portfolio

Table 71 : Myriad Genetics Inc.: Company Snapshot

Table 72 : Myriad Genetics Inc.: Financial Performance, FY 2022 and 2023

Table 73 : Myriad Genetics Inc.: Product Portfolio

Table 74 : QIAGEN.: Company Snapshot

Table 75 : QIAGEN.: Financial Performance, FY 2022 and 2023

Table 76 : QIAGEN.: Product Portfolio

Table 77 : Thermo Fisher Scientific Inc.: Company Snapshot

Table 78 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023

Table 79 : Thermo Fisher Scientific Inc.: Product Portfolio

Table 80 : ZytoVision GmbH: Company Snapshot

Table 81 : ZytoVision GmbH: Product Portfolio

List of Figures

Summary Figure A : Global Tissue Diagnostics Market, by Product Type, 2021-2029

Summary Figure B : Shares of Global Market for Tissue Diagnostics, by Product Type, 2023

Figure 1 : Market Dynamics of Tissue Diagnostics

Figure 2 : Shares of All Cancer Cases, by Region, 2022

Figure 3 : Emerging Trends and Technologies in Tissue Diagnostics

Figure 4 : Shares of Global Market for Tissue Diagnostics, by Technology, 2023

Figure 5 : Shares of Global Market for Tissue Diagnostics, by Segment Type, 2023

Figure 6 : Shares of Global Market for Histopathology, by Product Type, 2023

Figure 7 : Shares of Global Market for Molecular Pathology, by Product Type, 2023

Figure 8 : Shares of Global Market for Microbiology Testing, by Product Type, 2023

Figure 9 : Shares of Global Market for Tissue Diagnostics, by Application, 2023

Figure 10 : Shares of Global Market for Tissue Diagnostics, by End User, 2023

Figure 11 : Shares of Global Market for Tissue Diagnostics, by Region, 2023

Figure 12 : Shares of North American Market for Tissue Diagnostics, by Country, 2023

Figure 13 : Shares of European Market for Tissue Diagnostics, by Country, 2023

Figure 14 : Shares of Asia-Pacific Market for Tissue Diagnostics, by Country, 2023

Figure 15 : Shares of Latin American Tissue Diagnostics Market, by Country, 2023

Figure 16 : Shares of Global Market for Tissue Diagnostics, by Company, 2023

Figure 17 : ESG Pillars

Figure 18 : Advantages of ESG for Companies

Figure 19 : Abbott: Revenue Shares, by Business Unit, FY 2023

Figure 20 : Abbott: Revenue Shares, by Country/Region, FY 2023

Figure 21 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 22 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2023

Figure 23 : BD: Revenue Shares, by Business Unit, FY 2023

Figure 24 : BD: Revenue Shares, by Country/Region, FY 2023

Figure 25 : Biomerieux: Revenue Shares, by Business Unit, FY 2023

Figure 26 : Biomerieux: Revenue Shares, by Country/Region, FY 2023

Figure 27 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 28 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023

Figure 29 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023

Figure 30 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023

Figure 31 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023

Figure 32 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023

Figure 33 : Illumina Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 34 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2023

Figure 35 : Koninklijke Philips N.V.: Revenue Shares, by Business Unit, FY 2023

Figure 36 : Koninklijke Philips N.V.: Revenue Shares, by Country/Region, FY 2023

Figure 37 : Merck KGaA: Market Shares, by Business Unit, FY 2023

Figure 38 : Merck KGaA: Revenue Shares, by Country/Region, FY 2023

Figure 39 : Myriad Genetics Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 40 : Myriad Genetics Inc.: Revenue Shares, by Country/Region, FY 2023

Figure 41 : QIAGEN.: Revenue Shares, by Business Unit, FY 2023

Figure 42 : QIAGEN.: Revenue Shares, by Country/Region, FY 2023

Figure 43 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 44 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
• 免疫療法薬の世界市場 2025-11-12
• 農業におけるAIの世界市場 2025-11-10
• 固体酸化物形燃料電池の技術と世界市場 2025-11-07
• 世界の電気アーク炉市場 2025-11-07

BCC Research  出版レポート一覧